Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
MousePheno	abnormal skeletal muscle fiber type ratio	MYH1 MYH4 NEB FOXJ3 ZNF106	3.14e-05	40	129	5	MP:0009409
MousePheno	skeletal muscle fiber degeneration	FLNC MYH4 EPG5 ZNF106	3.67e-05	21	129	4	MP:0009412
MousePheno	impaired skeletal muscle contractility	MYH1 MYH4 NEB FOXJ3 DST	5.04e-05	44	129	5	MP:0002841
Domain	HEAT_REPEAT	SCYL3 MTOR PDS5A PRKDC NIPBL KPNB1	2.80e-05	70	158	6	PS50077
Domain	HEAT	SCYL3 MTOR PRKDC NIPBL KPNB1	1.30e-04	58	158	5	IPR000357
Domain	POLO_box_2	PLK2 PLK1	2.12e-04	3	158	2	IPR033695
Domain	CAF1C_H4-bd	RBBP4 RBBP7	2.12e-04	3	158	2	PF12265
Domain	Histone-bd_RBBP4_N	RBBP4 RBBP7	2.12e-04	3	158	2	IPR022052
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	VAPA MYH1 FLNC MYH4 ABI3BP BCLAF1 NMRAL1 PRPF6 ZFC3H1 CCDC77 NEB LARP7 NUP205 GRPEL1 ARRB1 DST SHANK2 BRD2 BRCA1 TESMIN SUGCT BAZ1A SEC62 PRKDC DNAJA1 NIPBL PLXNA2 DOP1A KPNB1	3.31e-11	1442	163	29	35575683
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	VAPA PLK2 RBBP4 BCLAF1 POLR2A APC PRPF6 LARP7 ZNF106 ARRB1 GTF2I NDC1 P3H1 SVIL RBAK PDS5A LTV1 PRKDC PLK1 DNAJA1 NIPBL CCDC9 DYNC1H1 VPS13B KPNB1	1.96e-10	1155	163	25	20360068
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	FLNC RBBP4 RBBP7 POLR2A PRPF6 LARP7 PPM1G NUP205 KARS1 GTF2I DST MTOR ASNS PDS5A PRKDC DNAJA1 NIPBL DYNC1H1 KPNB1	2.93e-10	653	163	19	22586326
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	VAPA NDUFB11 RBBP4 BCLAF1 RALGAPB CCDC18 RPS13 APEH RTN3 ATP6V1F PRPF6 ZFC3H1 CCDC77 GPRIN1 LARP7 PPM1G GRPEL1 NDC1 BRD2 P3H1 ASNS TMEM209 AKAP13 LTV1 PEAK1 DNAJA1 MAP4K4 VPS13B	3.37e-10	1487	163	28	33957083
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	VAPA RBBP4 BCLAF1 POLR2A RPS13 RTN3 PRPF6 ADAR LAP3 LARP7 NUP205 KARS1 GTF2I NDC1 BAZ1A MTOR ASNS PDS5A LTV1 PRKDC PEAK1 DNAJA1 MAP4K4 NIPBL DYNC1H1 MGAM2 KPNB1	6.37e-10	1425	163	27	30948266
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	VAPA RBBP4 RBBP7 BCLAF1 POLR2A RPS13 ZNF629 PRPF6 ZFC3H1 MLXIP ADAR ZNF106 KARS1 GTF2I NDC1 DST BRD2 BRCA1 BAZ1A TMEM209 PDS5A PRKDC DNAJA1 NIPBL KPNB1	2.01e-09	1294	163	25	30804502
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	RBBP4 RBBP7 BCLAF1 POLR2A GPRIN1 ADAR STAT3 GTF2I OSBPL11 PRKDC TAF2 PEAK1 PLK1 MAP4K4 DYNC1H1 KPNB1	7.86e-09	549	163	16	38280479
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	FLNC RBBP4 BCLAF1 POLR2A ZNF629 APC PRPF6 USP9Y ADAR NUP205 KARS1 DST BRD2 VCAN PDS5A PPIL2 PRKDC DNAJA1 MAP4K4 NIPBL DYNC1H1 KPNB1	8.28e-09	1082	163	22	38697112
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	FLNC RBBP7 BCLAF1 POLR2A RPS13 PRPF6 ADAR LAP3 PPM1G NUP205 ZNF106 KARS1 GTF2I NDC1 BRD2 ZNF592 PPIL2 PRKDC PLK1 DNAJA1 KPNB1	8.85e-09	989	163	21	36424410
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	VAPA RBBP4 POLR2A RPS13 PRPF6 ADAR STAT3 NUP205 KARS1 GTF2I MTOR ASNS PDS5A PRKDC DNAJA1 DYNC1H1 KPNB1	9.82e-09	638	163	17	33239621
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	VAPA GALNT14 NDUFB11 FLNC PLK2 RBBP7 BCLAF1 MXRA8 ZNF629 RTN3 ZFC3H1 STAT3 NUP205 ZNF106 NDC1 SEC62 RBAK TMEM209 PDS5A PRKDC TAF2 ZNF239 KPNB1	1.15e-08	1203	163	23	29180619
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	RBBP4 RBBP7 BCLAF1 POLR2A PRPF6 ADAR STAT3 LARP7 PPM1G NUP205 KARS1 GTF2I BRD2 ZNF592 BAZ1A ASNS PDS5A PRKDC TAF2 DNAJA1 NIPBL	1.36e-08	1014	163	21	32416067
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	FLNC RBBP4 RBBP7 POLR2A RPS13 APEH ATP6V1F LAP3 STAT3 LARP7 PPM1G NUP205 GRPEL1 KARS1 GTF2I MTOR P3H1 ASNS OSBPL11 PXN LTV1 PRKDC DNAJA1 DYNC1H1 KPNB1	2.05e-08	1455	163	25	22863883
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	VAPA CHSY1 RTN3 PPM1G NUP205 FZD6 KARS1 NDC1 MTOR P3H1 SEC62 ASNS TMEM209 PDS5A PPIL2 LTV1 PRKDC DNAJA1 DYNC1H1 KPNB1	2.06e-08	942	163	20	31073040
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	PLK2 RBBP7 INPP5E RALGAPB CCDC18 ZNF629 APC MLXIP STAT3 ZNF106 DST MTOR SVIL OSBPL10 AKAP13 PEAK1 PLK1 MAP4K4 DOP1A	2.61e-08	861	163	19	36931259
Pubmed	Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.	VAPA FLNC RBBP4 RBBP7 RPS13 APC PRPF6 MLXIP LARP7 KARS1 GTF2I ZNF592 ASNS PRKDC PLK1 DNAJA1 DYNC1H1 KPNB1	5.50e-08	809	163	18	32129710
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	MYH1 MYH4 POLR2A RPS13 GPRIN1 NUP205 KARS1 DST ZNF592 BTD P3H1 ASNS PDS5A AKAP13 PRKDC DNAJA1 DYNC1H1	7.75e-08	736	163	17	29676528
Pubmed	Proteomic characterization of chromosomal common fragile site (CFS)-associated proteins uncovers ATRX as a regulator of CFS stability.	VAPA RBBP4 RBBP7 BCLAF1 POLR2A RPS13 PRPF6 ADAR NUP205 GTF2I BRCA1 SVIL PDS5A PRKDC NIPBL KPNB1	8.44e-08	652	163	16	31180492
Pubmed	A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis.	FLNC RBBP7 KARS1 SVIL ASNS PDS5A PRKDC DYNC1H1	9.25e-08	118	163	8	27377895
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	FLNC RASA3 RBBP4 POLR2A RPS13 PRPF6 ADAR NUP205 KARS1 GTF2I DST BAZ1A ASNS PDS5A AKAP13 LTV1 PRKDC TAF2 PLK1 DNAJA1 NIPBL DYNC1H1 KPNB1	9.72e-08	1353	163	23	29467282
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	PRPF6 ZFC3H1 CCDC77 ZNF106 BRD2 BRCA1 PDS5A PPIL2 PLK1 NIPBL	1.08e-07	222	163	10	37071664
Pubmed	The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.	RBBP4 RBBP7 BCLAF1 POLR2A ZNF629 PRPF6 NUP205 GTF2I ZNF592 BAZ1A PDS5A PRKDC PLK1 DNAJA1 KPNB1	1.19e-07	583	163	15	29844126
Pubmed	The functional interactome landscape of the human histone deacetylase family.	RBBP4 RBBP7 BCLAF1 POLR2A MDM1 PRPF6 ADAR ZNF592 SVIL PRKDC DNAJA1	1.35e-07	289	163	11	23752268
Pubmed	Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation.	RBBP7 BCLAF1 POLR2A RPS13 APC ZFC3H1 BRCA1 SVIL AKAP13 PEAK1 DNAJA1 KPNB1	1.55e-07	361	163	12	30344098
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	CCDC30 BCLAF1 SCYL3 APC APEH GPRIN1 PPM1G GTF2I NDC1 DST BRCA1 OSBPL10 PDS5A PRKDC PEAK1 PCDH9 DYNC1H1	1.67e-07	777	163	17	35844135
Pubmed	FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.	RBBP7 BCLAF1 POLR2A RALGAPB RPS13 PRPF6 ADAR KARS1 BRD2 AKAP13 LTV1 PRKDC DNAJA1 MAP4K4 DYNC1H1	1.76e-07	601	163	15	33658012
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	VAPA BCLAF1 RPS13 APC GPRIN1 STAT3 PPM1G DST PDS5A LTV1 PRKDC PEAK1 DNAJA1 MAP4K4 DYNC1H1 KPNB1	2.56e-07	708	163	16	39231216
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	RBBP4 BCLAF1 ZNF629 APEH PRPF6 FOXJ3 ADAR PPM1G KARS1 GTF2I BRCA1 ASNS RBAK PDS5A PPIL2 PRKDC PLK1 NIPBL DYNC1H1 KPNB1	2.62e-07	1103	163	20	34189442
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	FLNC RBBP4 BCLAF1 POLR2A RPS13 PRPF6 ADAR NUP205 NDC1 DST BRD2 BAZ1A SVIL PRKDC DNAJA1 MAP4K4 NIPBL DYNC1H1 KPNB1	3.78e-07	1024	163	19	24711643
Pubmed	In vitro nuclear interactome of the HIV-1 Tat protein.	RBBP4 RBBP7 POLR2A ADAR NUP205 BRD2 PDS5A PLK1 KPNB1	3.87e-07	195	163	9	19454010
Pubmed	Interleukin-12-induced interferon-gamma production by human peripheral blood T cells is regulated by mammalian target of rapamycin (mTOR).	STAT3 STAT4 MTOR	4.03e-07	4	163	3	15522880
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	RBBP4 PRPF6 ADAR STAT3 GTF2I NDC1 BAZ1A SEC62 ASNS PDS5A PLK1 DNAJA1 DYNC1H1 KPNB1	4.51e-07	560	163	14	35241646
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	RBBP4 POLR2A PRPF6 ADAR STAT3 LARP7 PPM1G FZD6 GTF2I SEC62 ASNS PPIL2 PRKDC CCDC9 KPNB1	5.03e-07	653	163	15	33742100
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	POLR2A PRPF6 KARS1 GTF2I BAZ1A ASNS PDS5A PRKDC DNAJA1 NIPBL DYNC1H1	5.37e-07	332	163	11	32786267
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	POLR2A SCYL3 RALGAPB CCDC18 CCDC77 GPRIN1 PPM1G GRPEL1 KARS1 NDC1 BRD2 PTPRJ P3H1 SVIL PXN PEAK1 PLK1 DNAJA1 KPNB1	5.43e-07	1049	163	19	27880917
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	VAPA FLNC BCLAF1 RPS13 PRPF6 ADAR PPM1G KARS1 GTF2I LTV1 PRKDC DNAJA1 MAP4K4 NIPBL DYNC1H1 DOP1A KPNB1	5.54e-07	847	163	17	35235311
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	PLK2 KDM4C NAP1L3 APC APEH NCKAP5 ZFC3H1 USP9Y DCN STAT3 FN3K ARRB1 DST BRD2 ZNF592 PRKDC DNAJA1 MAP4K4 NIPBL DYNC1H1 KPNB1	6.98e-07	1285	163	21	35914814
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	VAPA RBBP4 RBBP7 BCLAF1 PRPF6 STAT3 LARP7 PPM1G NUP205 KARS1 GTF2I NDC1 DST MTOR SEC62 ASNS TMEM209 PDS5A PRKDC DNAJA1 DYNC1H1 KPNB1	1.13e-06	1440	163	22	30833792
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	RBBP4 RBBP7 FOXJ3 PPM1G GTF2I BRD2 BRCA1 ZNF592 BAZ1A RBAK PDS5A PPIL2 TAF2 NIPBL	1.19e-06	608	163	14	36089195
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	TRAPPC11 POLR2A PRPF6 ADAR LAP3 NUP205 KARS1 MTOR ASNS PDS5A PRKDC PLK1 DNAJA1 NIPBL DYNC1H1	1.28e-06	704	163	15	29955894
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	RBBP4 POLR2A RPS13 ARRB1 GTF2I BRD2 ZNF592 BAZ1A ASNS TAF2 NIPBL DYNC1H1 KPNB1	1.55e-06	533	163	13	30554943
Pubmed	Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation.	POLR2A RPS13 APEH ADAR LAP3 NUP205 KARS1 GTF2I ASNS TMEM209 PRKDC DNAJA1 DYNC1H1	1.58e-06	534	163	13	35032548
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	RBBP4 BCLAF1 TEX15 NEB ADAR GTF2I DST LTV1 VPS13B	1.76e-06	234	163	9	36243803
Pubmed	BRCA1 interacts with components of the histone deacetylase complex.	RBBP4 RBBP7 BRCA1	2.00e-06	6	163	3	10220405
Pubmed	Expression, purification and characterization of the human MTA2-RBBP7 complex.	RBBP4 RBBP7 KPNB1	2.00e-06	6	163	3	28179136
Pubmed	EVI1 oncoprotein interacts with a large and complex network of proteins and integrates signals through protein phosphorylation.	RBBP4 NMRAL1 NUP205 GTF2I BRD2 PRKDC DYNC1H1	2.56e-06	128	163	7	23858473
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	VAPA APC APEH RTN3 PIR ADAR STAT3 ZNF106 NDC1 DST BAZ1A P3H1 SEC62 PDS5A AKAP13 PRKDC DNAJA1 NIPBL DYNC1H1 KPNB1	3.16e-06	1297	163	20	33545068
Pubmed	A human MAP kinase interactome.	FLNC ABI3BP APC NCKAP5 NEB ZNF106 ARRB1 DST AKAP13 VAV3 PRKDC MAP4K4	3.50e-06	486	163	12	20936779
Pubmed	Proteomic analysis of the SIRT6 interactome: novel links to genome maintenance and cellular stress signaling.	RBBP4 RBBP7 LARP7 GTF2I PDS5A PRKDC	3.57e-06	87	163	6	24169447
Pubmed	Charting the landscape of tandem BRCT domain-mediated protein interactions.	TRAPPC11 RBBP7 BCLAF1 POLR2A DCN LAP3 LARP7 PPM1G BRCA1 MTOR DNAJA1 MAP4K4 DYNC1H1 KPNB1	3.67e-06	670	163	14	22990118
Pubmed	Human transcription factor protein interaction networks.	VAPA RPS13 ZNF629 STAT3 STAT4 PPM1G NUP205 GRPEL1 GTF2I DST BRD2 BRCA1 ZNF592 SVIL PDS5A PPIL2 LTV1 TAF2 DNAJA1 NIPBL DYNC1H1	3.72e-06	1429	163	21	35140242
Pubmed	Methyltransferase-like 21e inhibits 26S proteasome activity to facilitate hypertrophy of type IIb myofibers.	VAPA FLNC RBBP4 RBBP7 MXRA8 PRPF6 LAP3 KARS1 KPNB1	4.04e-06	259	163	9	31162944
Pubmed	CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.	FLNC RBBP4 RPS13 APEH PRPF6 GRPEL1 KARS1 NDC1 BRCA1 PDS5A DNAJA1 KPNB1	4.13e-06	494	163	12	26831064
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	POLR2A PRPF6 USP9Y NEB GPRIN1 FN3K ZNF106 XIRP2 ZNF592 PLK1 MAP4K4 HYDIN	4.39e-06	497	163	12	36774506
Pubmed	The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1.	FOXJ3 LARP7 GRPEL1 DST BRD2 OSBPL11 TAF2 KPNB1	4.51e-06	197	163	8	20811636
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	VAPA NDUFB11 FLNC MXRA8 RPS13 GPX7 RTN3 PRPF6 ADAR LARP7 SEMA3A C1GALT1C1 KARS1 NDC1 GVINP1 FARS2 P3H1 SEC62 OSBPL11 MAP4K4 KPNB1	4.70e-06	1451	163	21	30550785
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	VAPA SCYL3 RTN3 ATP6V1F GPRIN1 NDC1 DST PARP16 TMEM209 OSBPL11 OSBPL10 VPS13B	5.06e-06	504	163	12	34432599
Pubmed	Proteomic analysis of DZIP3 interactome and its role in proliferation and metastasis in gastric cancer cells.	RBBP4 RBBP7 BAZ1A ASNS PRKDC	5.09e-06	53	163	5	36841324
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	VAPA FLNC MYH4 RBBP7 APC PRPF6 PPM1G NUP205 GTF2I BRCA1 FARS2 AFP P3H1 OSBPL11 OSBPL10 PLK1 MAP4K4	5.52e-06	1005	163	17	19615732
Pubmed	Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.	RBBP4 BCLAF1 PRPF6 ADAR GTF2I PDS5A PRKDC NIPBL DYNC1H1	6.01e-06	272	163	9	31010829
Pubmed	Network organization of the human autophagy system.	TRAPPC11 FLNC MYH4 RBBP7 LAP3 NUP205 XIRP2 MTOR ASNS PRKDC PLK1	7.54e-06	437	163	11	20562859
Pubmed	Physiological and pathophysiological characteristics of ataxin-3 isoforms.	RBBP4 RPS13 GRPEL1 KARS1 GTF2I PRKDC DNAJA1 DYNC1H1 KPNB1	7.80e-06	281	163	9	30455355
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	FLNC RBBP4 RBBP7 RPS13 PRPF6 ADAR LAP3 PPM1G KARS1 GTF2I DST SVIL ASNS PDS5A PRKDC DNAJA1 DYNC1H1 KPNB1	8.22e-06	1149	163	18	35446349
Pubmed	ORP/Osh mediate cross-talk between ER-plasma membrane contact site components and plasma membrane SNAREs.	VAPA OSBPL11 OSBPL10	8.32e-06	9	163	3	32734583
Pubmed	A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathies.	TDRD9 RBBP4 BCLAF1 TEX15 DST GVINP1 DNAJA1 MAP4K4 DYNC1H1	8.50e-06	284	163	9	29459677
Pubmed	Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer.	VAPA RBBP4 RBBP7 BCLAF1 RPS13 PRPF6 ADAR GTF2I SVIL PRKDC DNAJA1 DYNC1H1 KPNB1	8.83e-06	626	163	13	33644029
Pubmed	Prohibitin 1 regulates tumor cell apoptosis via the interaction with X-linked inhibitor of apoptosis protein.	FLNC RBBP4 POLR2A RPS13 USP9Y ADAR GRPEL1 KARS1 FARS2 LTV1 PRKDC DNAJA1 DYNC1H1 KPNB1	8.97e-06	725	163	14	27025967
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	TMEM161B RPS13 FOXJ3 STAT3 TENM4 FARS2 SVIL OSBPL11 PXN PEAK1 MAP4K4 NIPBL	9.39e-06	536	163	12	15840001
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	GALNT14 PLK2 RBBP4 RBBP7 BCLAF1 POLR2A APC PELI1 ADAM30 GCNT7 BRD2 ENTPD1 PPIL2 PLK1	9.69e-06	730	163	14	34857952
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	TMEM161B RPS13 FOXJ3 STAT3 TENM4 FARS2 SVIL OSBPL11 PXN PEAK1 MAP4K4 NIPBL	9.75e-06	538	163	12	10512203
Pubmed	Defining the membrane proteome of NK cells.	ICAM2 RPS13 CHSY1 PRPF6 CCDC77 ADAR NUP205 GTF2I NDC1 MTOR PARP16 P3H1 ENTPD1 AKAP13 PRKDC DNAJA1 DYNC1H1 KPNB1	1.03e-05	1168	163	18	19946888
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	BCLAF1 POLR2A PRPF6 ADAR STAT3 SASH3 BAZ1A PPIL2 PLK1 DYNC1H1	1.07e-05	370	163	10	22922362
Pubmed	Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization.	PRKDC DNAJA1 DYNC1H1	1.18e-05	10	163	3	19826009
Pubmed	During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation.	MYH1 FLNC MYH4	1.18e-05	10	163	3	19506036
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	BCLAF1 POLR2A CCDC18 ZNF629 CCDC77 LARP7 PPM1G KARS1 DST BRD2 BRCA1 ZNF592 PPIL2	1.21e-05	645	163	13	25281560
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	APC MLXIP CCDC77 STAT3 NUP205 SVIL TMEM209 PXN LTV1 TAF2 PLK1 DNAJA1 MAP4K4 DYNC1H1 KPNB1	1.29e-05	853	163	15	28718761
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	RBBP4 RBBP7 NUP205 BRD2 ZNF592 BAZ1A PDS5A TAF2 CCDC9 HYDIN KPNB1	1.46e-05	469	163	11	27634302
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	RBBP4 RPS13 ZNF629 PRPF6 ZFC3H1 ADAR LARP7 NUP205 KARS1 BAZ1A LTV1 PRKDC PLK1 DNAJA1	1.49e-05	759	163	14	35915203
Pubmed	Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations.	FLNC LAP3 STAT3 SVIL ASNS PRKDC DNAJA1 DYNC1H1	1.63e-05	235	163	8	28378594
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	BCLAF1 POLR2A RALGAPB GPRIN1 ZNF106 GTF2I BRD2 ZNF592 SVIL OSBPL11 PRKDC MAP4K4 NIPBL CCDC9	1.85e-05	774	163	14	15302935
Pubmed	Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.	FLNC RBBP4 RBBP7 BCLAF1 APEH LAP3 PPM1G GTF2I BRD2 DNAJA1	2.05e-05	399	163	10	35987950
Pubmed	Interactions of Prototype Foamy Virus Capsids with Host Cell Polo-Like Kinases Are Important for Efficient Viral DNA Integration.	PLK2 PLK1	2.18e-05	2	163	2	27579920
Pubmed	Bpag1 localization to actin filaments and to the nucleus is regulated by its N-terminus.	DST PXN	2.18e-05	2	163	2	14576348
Pubmed	Versican but not decorin accumulation is related to malignancy in mammographically detected high density and malignant-appearing microcalcifications in non-palpable breast carcinomas.	DCN VCAN	2.18e-05	2	163	2	21791066
Pubmed	Role of crosstalk between STAT3 and mTOR signaling in driving sensitivity to chemotherapy in osteosarcoma cell lines.	STAT3 MTOR	2.18e-05	2	163	2	33448097
Pubmed	Variation in RTN3 and PPIL2 genes does not influence platelet membrane beta-secretase activity or susceptibility to alzheimer's disease in the northern Irish population.	RTN3 PPIL2	2.18e-05	2	163	2	19669607
Pubmed	Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL.	STAT3 MTOR	2.18e-05	2	163	2	28082737
Pubmed	Characterization of the gene encoding mouse retinoblastoma binding protein-7, a component of chromatin-remodeling complexes.	RBBP4 RBBP7	2.18e-05	2	163	2	12376095
Pubmed	Glycyrrhizic acid inhibits leukemia cell growth and migration via blocking AKT/mTOR/STAT3 signaling.	STAT3 MTOR	2.18e-05	2	163	2	26191214
Pubmed	Growth and muscle defects in mice lacking adult myosin heavy chain genes.	MYH1 MYH4	2.18e-05	2	163	2	9382868
Pubmed	mTORC1 is a critical mediator of oncogenic Semaphorin3A signaling.	SEMA3A MTOR	2.18e-05	2	163	2	27246732
Pubmed	Interpreting the molecular mechanisms of RBBP4/7 and their roles in human diseases (Review).	RBBP4 RBBP7	2.18e-05	2	163	2	38577935
Pubmed	STAT4 isoforms differentially regulate Th1 cytokine production and the severity of inflammatory bowel disease.	STAT4 PRKDC	2.18e-05	2	163	2	18802110
Pubmed	Polo-like kinases mediate cell survival in mitochondrial dysfunction.	PLK2 PLK1	2.18e-05	2	163	2	19706541
Pubmed	Polo-like kinase 1 (PLK1) and protein phosphatase 6 (PP6) regulate DNA-dependent protein kinase catalytic subunit (DNA-PKcs) phosphorylation in mitosis.	PRKDC PLK1	2.18e-05	2	163	2	24844881
Pubmed	The Catalytic Subunit of DNA-Dependent Protein Kinase Coordinates with Polo-Like Kinase 1 to Facilitate Mitotic Entry.	PRKDC PLK1	2.18e-05	2	163	2	25925375
Pubmed	Effects of mTOR-STAT3 on the migration and invasion abilities of hepatoma cell and mTOR-STAT3 expression in liver cancer.	STAT3 MTOR	2.18e-05	2	163	2	25063062
Pubmed	Plk1 Mediates Paxillin Phosphorylation (Ser-272), Centrosome Maturation, and Airway Smooth Muscle Layer Thickening in Allergic Asthma.	PXN PLK1	2.18e-05	2	163	2	31101859
Pubmed	SHF Acts as a Novel Tumor Suppressor in Glioblastoma Multiforme by Disrupting STAT3 Dimerization.	STAT3 SHF	2.18e-05	2	163	2	35843865
Pubmed	Frequency and histological appearance of adenomas in multiple intestinal neoplasia mice are unaffected by severe combined immunodeficiency (scid) mutation.	APC PRKDC	2.18e-05	2	163	2	8567125
Interaction	STAG2 interactions	RBBP4 RBBP7 BCLAF1 PRPF6 ADAR GTF2I BAZ1A PDS5A PRKDC PLK1 NIPBL	1.94e-06	224	161	11	int:STAG2
Interaction	H2BC21 interactions	RBBP4 RBBP7 BCLAF1 POLR2A NEB LARP7 PPM1G ADHFE1 BRD2 BRCA1 SASH3 BAZ1A P3H1 SVIL PRKDC MAP4K4 NIPBL LMNTD1 DYNC1H1	3.11e-06	696	161	19	int:H2BC21
Interaction	SLX4 interactions	POLR2A ZNF629 PRPF6 ZFC3H1 CCDC77 ADAR ZNF106 GTF2I BRD2 BRCA1 PDS5A PPIL2 PRKDC PLK1 NIPBL DYNC1H1 KPNB1	3.48e-06	572	161	17	int:SLX4
Interaction	TERF1 interactions	RTN3 FOXJ3 LARP7 PPM1G GRPEL1 DST BRCA1 MTOR PRKDC TAF2 PLK1 CCDC9 KPNB1	4.52e-06	347	161	13	int:TERF1
Interaction	SMC3 interactions	RBBP4 RBBP7 POLR2A APC PRPF6 ADAR BRCA1 BAZ1A PDS5A PRKDC PLK1 NIPBL DYNC1H1 KPNB1	5.28e-06	408	161	14	int:SMC3
Interaction	MECOM interactions	MYH1 FLNC MYH4 RBBP4 RBBP7 NMRAL1 NEB NUP205 GTF2I BRD2 PRKDC DYNC1H1 KPNB1	6.33e-06	358	161	13	int:MECOM
Interaction	BRCA1 interactions	FLNC RBBP4 RBBP7 POLR2A RPS13 APEH PRPF6 DCN STAT3 LARP7 GRPEL1 KARS1 GTF2I NDC1 DST BRCA1 MTOR PDS5A PRKDC PLK1 DNAJA1 MAP4K4 NIPBL LMNTD1 DYNC1H1 KPNB1	6.53e-06	1249	161	26	int:BRCA1
Interaction	SIRT7 interactions	FLNC RBBP4 RBBP7 POLR2A PRPF6 LARP7 PPM1G NUP205 KARS1 GTF2I DST MTOR ASNS PDS5A PRKDC DNAJA1 NIPBL DYNC1H1 KPNB1	8.08e-06	744	161	19	int:SIRT7
Interaction	H3C1 interactions	RBBP4 KDM4C RBBP7 POLR2A NEB GPRIN1 SIRT3 LARP7 PPM1G GRPEL1 BRD2 XIRP2 BAZ1A PXN PDS5A PPIL2 LTV1 PRKDC TAF2 NIPBL DYNC1H1	1.06e-05	901	161	21	int:H3C1
Interaction	PWWP2B interactions	RBBP4 RBBP7 BRD2 PRKDC	1.10e-05	18	161	4	int:PWWP2B
Interaction	ZYX interactions	SCYL3 APC APEH MLXIP LAP3 ARRB1 SVIL OSBPL11 PXN AKAP13 VAV3 PEAK1	1.39e-05	329	161	12	int:ZYX
Interaction	ZNF330 interactions	ZNF629 PRPF6 ZFC3H1 LARP7 PPM1G NUP205 ZNF106 BRD2 ZNF592 BAZ1A RBAK PDS5A PPIL2 NIPBL	1.44e-05	446	161	14	int:ZNF330
Interaction	RAD18 interactions	FLNC RBBP4 RBBP7 BCLAF1 PRPF6 KARS1 BRD2 BRCA1 SVIL ASNS PDS5A PRKDC TAF2 DYNC1H1	1.89e-05	457	161	14	int:RAD18
Interaction	YWHAG interactions	VAPA TRAPPC11 BCLAF1 INPP5E RALGAPB CCDC18 ZNF629 APC RTN3 MLXIP STAT3 ZNF106 ARRB1 DST BAZ1A MTOR SVIL OSBPL10 AKAP13 PRKDC PEAK1 PLK1 MAP4K4 DYNC1H1 DOP1A	1.93e-05	1248	161	25	int:YWHAG
Interaction	STAG1 interactions	RBBP4 RBBP7 ADAR BRCA1 BAZ1A PDS5A NIPBL	2.02e-05	104	161	7	int:STAG1
Interaction	IGF1R interactions	VAPA TRAPPC11 ATP6V1F STAT3 ARRB1 NDC1 MTOR OSBPL11 PXN VAV3 PRKDC PEAK1 DNAJA1 MAP4K4	2.40e-05	467	161	14	int:IGF1R
Interaction	LUC7L2 interactions	VAPA RBBP4 RBBP7 BCLAF1 PRPF6 STAT3 LARP7 SVIL VAV3 DNAJA1 CCDC9 DYNC1H1	2.79e-05	353	161	12	int:LUC7L2
Interaction	RAC2 interactions	VAPA RASA3 RTN3 ATP6V1F GPRIN1 NUP205 FZD6 NDC1 DST PTPRJ MTOR TMEM209 OSBPL11 OSBPL10 PEAK1 MAP4K4 VPS13B	2.92e-05	674	161	17	int:RAC2
Interaction	MECP2 interactions	FLNC RBBP4 BCLAF1 POLR2A ZNF629 APC PRPF6 USP9Y ADAR NUP205 KARS1 DST BRD2 BAZ1A VCAN RBAK PDS5A PPIL2 PRKDC PLK1 DNAJA1 MAP4K4 NIPBL DYNC1H1 KPNB1	3.22e-05	1287	161	25	int:MECP2
Interaction	SMC1A interactions	RBBP4 RBBP7 POLR2A RPS13 PRPF6 ADAR LARP7 BRCA1 BAZ1A PDS5A PRKDC PLK1 NIPBL	3.25e-05	418	161	13	int:SMC1A
Interaction	EBAG9 interactions	VAPA TRAPPC11 POLR2A SCYL3 NDC1 DST SEC62 PEAK1 DNAJA1 MAP4K4 VPS13B	3.34e-05	303	161	11	int:EBAG9
Interaction	ANKRD44 interactions	PLK2 ARRB1 BRCA1 ENTPD1 PLK1	3.97e-05	48	161	5	int:ANKRD44
Interaction	POLR1G interactions	POLR2A PRPF6 ZFC3H1 LARP7 PPM1G NUP205 ZNF106 ARRB1 BRD2 ZNF592 PDS5A PPIL2 TAF2 NIPBL	3.97e-05	489	161	14	int:POLR1G
Interaction	USP7 interactions	RBBP4 BCLAF1 NMRAL1 NAP1L3 APC TEX15 NEB PIR ADAR PPM1G FZD6 C1GALT1C1 GTF2I TENM4 DST BRCA1 SASH3 SVIL ARNT2 PXN LTV1 PLK1 DYNC1H1 VPS13B TTLL13	4.47e-05	1313	161	25	int:USP7
Interaction	STYK1 interactions	SCYL3 ATP6V1F NUP205 DST MDH1B PRKDC MAP4K4 VPS13B	4.65e-05	161	161	8	int:STYK1
Interaction	FGFR3 interactions	FSTL4 ATP6V1F GPRIN1 STAT3 LARP7 NUP205 KARS1 BRD2 BAZ1A PRKDC DYNC1H1	4.75e-05	315	161	11	int:FGFR3
Interaction	CENPA interactions	RBBP4 RBBP7 PRPF6 PPM1G NUP205 GTF2I BRD2 BAZ1A PDS5A PPIL2 PRKDC NIPBL	5.27e-05	377	161	12	int:CENPA
Interaction	STIP1 interactions	VAPA RBBP4 POLR2A RPS13 PRPF6 NEB ADAR STAT3 NUP205 ADGB GRPEL1 KARS1 GTF2I BRCA1 MTOR ASNS PDS5A PRKDC DNAJA1 DYNC1H1 KPNB1	5.34e-05	1006	161	21	int:STIP1
Interaction	PTHLH interactions	ARRB1 PLK1 KPNB1	5.76e-05	10	161	3	int:PTHLH
Interaction	THRAP3 interactions	PLK2 RBBP4 RBBP7 BCLAF1 CPZ PRPF6 LARP7 PPM1G ARRB1 PDS5A DNAJA1 NIPBL KPNB1	5.88e-05	443	161	13	int:THRAP3
Interaction	SYNE3 interactions	VAPA GALNT14 CCDC18 NMRAL1 APC RTN3 NDC1 DST P3H1 SEC62 TMEM209 PLK1 KPNB1	6.02e-05	444	161	13	int:SYNE3
Interaction	P2RY6 interactions	RBBP7 PPM1G GTF2I NDC1 PTPRJ MTOR SEC62 TMEM209 PDS5A PRKDC DNAJA1 KPNB1	6.44e-05	385	161	12	int:P2RY6
Interaction	YWHAH interactions	VAPA TRAPPC11 INPP5E RALGAPB CCDC18 ZNF629 APC PRPF6 MLXIP ZNF106 GRPEL1 ARRB1 DST MTOR SVIL OSBPL10 AKAP13 PPIL2 PEAK1 PLK1 MAP4K4 DOP1A	6.77e-05	1102	161	22	int:YWHAH
Interaction	LMBR1L interactions	VAPA CHSY1 RTN3 PPM1G NUP205 FZD6 KARS1 NDC1 MTOR P3H1 SEC62 ASNS TMEM209 PDS5A PPIL2 LTV1 PRKDC DNAJA1 DYNC1H1 KPNB1	6.86e-05	946	161	20	int:LMBR1L
Interaction	GJA1 interactions	VAPA FLNC RASA3 SCYL3 APC GPRIN1 PPM1G GTF2I NDC1 DST TMEM209 PEAK1 MAP4K4 PCDH9 VPS13B	7.04e-05	583	161	15	int:GJA1
Interaction	SUMO2 interactions	RBBP4 RBBP7 POLR2A PRPF6 KARS1 GTF2I DST BRCA1 BAZ1A ASNS PDS5A PRKDC DNAJA1 NIPBL DYNC1H1	8.20e-05	591	161	15	int:SUMO2
Interaction	PPP1CC interactions	RBBP7 BCLAF1 POLR2A NMRAL1 RPS13 ZNF629 APC ZFC3H1 LARP7 BRCA1 SVIL AKAP13 PEAK1 PLK1 DNAJA1 MAP4K4 KPNB1	8.95e-05	738	161	17	int:PPP1CC
Interaction	LLGL2 interactions	BCLAF1 ZNF592 MTOR SVIL PDS5A DNAJA1 DYNC1H1	9.76e-05	133	161	7	int:LLGL2
Interaction	CIC interactions	RBBP4 RBBP7 BCLAF1 POLR2A ZNF629 PRPF6 NUP205 GTF2I ZNF592 BAZ1A SEC62 PDS5A PRKDC PLK1 DNAJA1 KPNB1	1.01e-04	673	161	16	int:CIC
Interaction	FBXW7 interactions	PLK2 RBBP4 RBBP7 BCLAF1 POLR2A RALGAPB RPS13 ATP6V1F PRPF6 ADAR STAT3 KARS1 BRD2 MTOR AKAP13 LTV1 PRKDC PLK1 DNAJA1 MAP4K4 DYNC1H1 KPNB1 GULP1	1.02e-04	1215	161	23	int:FBXW7
Interaction	H3-3A interactions	RBBP4 KDM4C RBBP7 FOXJ3 PPM1G GTF2I BRD2 BRCA1 ZNF592 BAZ1A RBAK PDS5A PPIL2 PRKDC TAF2 DNAJA1 NIPBL	1.07e-04	749	161	17	int:H3-3A
Interaction	RNF123 interactions	MYH1 FLNC MYH4 POLR2A RPS13 GPRIN1 NUP205 KARS1 DST ZNF592 BTD P3H1 ASNS PDS5A AKAP13 PRKDC DNAJA1 DYNC1H1	1.08e-04	824	161	18	int:RNF123
Interaction	RAB11A interactions	VAPA SCYL3 RALGAPB RTN3 GPRIN1 NUP205 GRPEL1 KARS1 NDC1 DST PTPRJ SEC62 OSBPL11 OSBPL10 PEAK1 MAP4K4 VPS13B DOP1A	1.18e-04	830	161	18	int:RAB11A
Interaction	CEBPA interactions	RASGRF1 RBBP4 BCLAF1 POLR2A ZNF629 APEH PRPF6 FOXJ3 ADAR PPM1G KARS1 GTF2I BRCA1 BAZ1A ASNS RBAK PDS5A PPIL2 PRKDC PLK1 NIPBL DYNC1H1 KPNB1	1.46e-04	1245	161	23	int:CEBPA
Interaction	WWTR1 interactions	RBBP7 POLR2A GPRIN1 ADAR STAT3 GTF2I ARNT2 OSBPL11 PEAK1 PLK1 MAP4K4 KPNB1	1.53e-04	422	161	12	int:WWTR1
Interaction	BIRC3 interactions	VAPA RBBP4 BCLAF1 POLR2A RPS13 RTN3 PELI1 PRPF6 ADAR LAP3 NUP205 KARS1 GTF2I NDC1 BAZ1A MTOR ASNS PDS5A PRKDC PEAK1 DNAJA1 DYNC1H1 MGAM2 KPNB1	1.54e-04	1334	161	24	int:BIRC3
Interaction	SIRT6 interactions	RBBP4 RBBP7 BCLAF1 POLR2A APC PRPF6 ZFC3H1 ADAR LARP7 NUP205 GTF2I ZNF592 TMEM209 PDS5A PRKDC	1.60e-04	628	161	15	int:SIRT6
Interaction	YWHAE interactions	VAPA TRAPPC11 RASGRF1 RBBP4 INPP5E RALGAPB CCDC18 ZNF629 APC MLXIP ZNF106 GRPEL1 ARRB1 DST BRCA1 MTOR SVIL ASNS AKAP13 PEAK1 DNAJA1 DYNC1H1 KPNB1	1.66e-04	1256	161	23	int:YWHAE
Interaction	YWHAB interactions	VAPA TRAPPC11 RASGRF1 INPP5E RALGAPB CCDC18 ZNF629 APC RTN3 PRPF6 MLXIP NEB ZNF106 ARRB1 DST MTOR SVIL AKAP13 PEAK1 DYNC1H1	1.75e-04	1014	161	20	int:YWHAB
Interaction	H2AZ1 interactions	VAPA PLK2 RBBP4 RBBP7 LARP7 PPM1G BRD2 BAZ1A PRKDC MAP4K4 DYNC1H1	2.02e-04	371	161	11	int:H2AZ1
Interaction	FLNA interactions	FLNC RBBP4 RBBP7 APC DCN LARP7 KARS1 ARRB1 BRCA1 SEC62 SVIL PDS5A PRKDC NIPBL DYNC1H1	2.24e-04	648	161	15	int:FLNA
Interaction	HIF1A interactions	MYH1 MYH4 KDM4C PRPF6 STAT3 ARRB1 GTF2I BRCA1 MTOR ARNT2 PRKDC DNAJA1	2.29e-04	441	161	12	int:HIF1A
Interaction	RAD21 interactions	RBBP4 RBBP7 RPS13 ADAR BRCA1 XIRP2 BAZ1A PDS5A PRKDC NIPBL KPNB1	2.71e-04	384	161	11	int:RAD21
Interaction	TRIM28 interactions	TRAPPC11 ZNF527 RBBP4 RBBP7 POLR2A PRPF6 ADAR LAP3 STAT3 LARP7 STAT4 PPM1G ZNF585B NUP205 KARS1 BRCA1 MTOR ASNS RBAK PDS5A PRKDC PLK1 DNAJA1 NIPBL DYNC1H1	2.75e-04	1474	161	25	int:TRIM28
Interaction	NR3C1 interactions	TRAPPC11 NAP1L3 ADAM30 NEB DCN FOXJ3 STAT3 LARP7 C1GALT1C1 KARS1 ARRB1 SVIL LPO LTV1 PRKDC TAF2 FER1L5 NIPBL KPNB1	2.94e-04	974	161	19	int:NR3C1
Interaction	RAB9A interactions	VAPA SCYL3 RALGAPB RTN3 ATP6V1F NUP205 GRPEL1 KARS1 NDC1 DST TMEM209 OSBPL11 PEAK1 VPS13B	3.09e-04	595	161	14	int:RAB9A
Interaction	KDM5A interactions	RBBP4 RBBP7 LARP7 BRD2 PDS5A	3.16e-04	74	161	5	int:KDM5A
Interaction	BCL2L1 interactions	BCLAF1 BRD2 MTOR SVIL PXN PDS5A PRKDC PLK1	3.22e-04	213	161	8	int:BCL2L1
Interaction	OBSL1 interactions	FLNC RBBP4 BCLAF1 POLR2A PRPF6 ADAR LARP7 NUP205 NDC1 DST BRD2 PRKDC DNAJA1 MAP4K4 NIPBL DYNC1H1 MGAM2 KPNB1	3.27e-04	902	161	18	int:OBSL1
Interaction	RHOF interactions	VAPA RASA3 RALGAPB RPS13 GPRIN1 PPM1G NUP205 NDC1 PTPRJ MTOR TMEM209 PRKDC PEAK1 MAP4K4 VPS13B	3.35e-04	673	161	15	int:RHOF
Interaction	AR interactions	KDM4C RPS13 PRPF6 ADAR STAT3 KARS1 GTF2I BRD2 BRCA1 SVIL ASNS RBAK PXN PDS5A VAV3 PRKDC DNAJA1 NIPBL DYNC1H1	3.70e-04	992	161	19	int:AR
Interaction	LMNTD1 interactions	BRCA1 LMNTD1	3.77e-04	4	161	2	int:LMNTD1
Interaction	AURKC interactions	MYH1 MYH4 BRD2 BRCA1	3.80e-04	43	161	4	int:AURKC
Interaction	NUMA1 interactions	RBBP4 DCAF8L2 RPS13 ADAR NUP205 GTF2I BRD2 BRCA1 BAZ1A MAP4K4 DYNC1H1 KPNB1	4.00e-04	469	161	12	int:NUMA1
Interaction	USP11 interactions	VAPA RBBP4 RBBP7 FOXJ3 SIRT3 BRCA1 MTOR ASNS OSBPL10 PLK1 DNAJA1 DYNC1H1 KPNB1	4.03e-04	539	161	13	int:USP11
Interaction	SRI interactions	VAPA PIR STAT3 BRCA1 PLK1	4.03e-04	78	161	5	int:SRI
Interaction	FBXO22 interactions	KDM4C POLR2A PRPF6 USP9Y NEB GPRIN1 FN3K ZNF106 XIRP2 ZNF592 PLK1 MAP4K4 HYDIN	4.10e-04	540	161	13	int:FBXO22
Interaction	H2BC3 interactions	RBBP4 PRPF6 LARP7 PPM1G GTF2I BRD2 BRCA1 BAZ1A PDS5A PRKDC DNAJA1	4.34e-04	406	161	11	int:H2BC3
Interaction	RUVBL2 interactions	RBBP4 RBBP7 POLR2A APC ADAR LARP7 BRD2 BRCA1 MTOR PRKDC DNAJA1 NIPBL DYNC1H1 KPNB1	4.37e-04	616	161	14	int:RUVBL2
Interaction	DSCAM interactions	KDM4C POLR2A STAT3 DST MAP4K4 DYNC1H1 KPNB1	4.57e-04	171	161	7	int:DSCAM
Interaction	PTEN interactions	RBBP7 POLR2A RPS13 RTN3 GPRIN1 ADAR PPM1G ARRB1 MTOR AFP P3H1 PXN AKAP13 LTV1 PRKDC PLK1 DNAJA1 KPNB1	4.64e-04	929	161	18	int:PTEN
Interaction	C9orf78 interactions	RBBP4 PRPF6 ADAR STAT3 GTF2I NDC1 BAZ1A SEC62 ASNS PDS5A PLK1 DNAJA1 DYNC1H1 KPNB1	4.66e-04	620	161	14	int:C9orf78
GeneFamily	Lysine methyltransferases\|Myb/SANT domain containing\|Polycomb repressive complex 2	RBBP4 RBBP7	4.84e-04	6	104	2	1347
GeneFamily	Histone deacetylases, class I\|EMSY complex\|NuRD complex\|SIN3 histone deacetylase complex	RBBP4 RBBP7	1.15e-03	9	104	2	1306
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	RASGRF1 RASA3 OSBPL11 OSBPL10 AKAP13 VAV3	1.22e-03	206	104	6	682
GeneFamily	Histone deacetylases, class I\|EMSY complex\|NuRD complex\|SIN3 histone deacetylase complex	RBBP4 RBBP7	2.08e-03	12	104	2	1243
GeneFamily	Oxysterol binding proteins\|Pleckstrin homology domain containing	OSBPL11 OSBPL10	2.08e-03	12	104	2	670
GeneFamily	PHD finger proteins\|NuRD complex	RBBP4 RBBP7	2.08e-03	12	104	2	1305
GeneFamily	SH2 domain containing	STAT3 STAT4 SHF VAV3	2.75e-03	101	104	4	741
GeneFamily	Myosin heavy chains	MYH1 MYH4	3.28e-03	15	104	2	1098
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3	MDM1 CCDC18 RTN3 PRPF6 BRCA1 BAZ1A PDS5A PRKDC DNAJA1 NIPBL	1.81e-06	192	158	10	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#5_top-relative-expression-ranked_200	APC PELI1 TENM4 VCAN KPNB1 GULP1	1.26e-05	69	158	6	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200_k5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500	RBBP4 APC PELI1 GTF2I VCAN ARNT2 PLXNA2 KPNB1 GULP1	2.76e-05	209	158	9	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	FLNC ABI3BP RASA3 CCDC18 CHSY1 CPZ DCN SVEP1 SEMA3A TENM4 P3H1 VCAN SVIL SORCS3 PEAK1 PCDH9 GULP1	7.04e-05	777	158	17	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	RASA3 SPSB1 CHSY1 STAT3 BAZ1A SVIL AKAP13 PEAK1 MAP4K4 PLXNA2	2.48e-09	192	163	10	8b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	ABI3BP RASA3 SVEP1 STAT4 DST VCAN SVIL OSBPL10 AKAP13	2.74e-08	184	163	9	d2bf0135eb56bb410997dccea39c5ede88a0617f
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	NCKAP5 SHANK2 PTPRJ SUGCT SVIL OSBPL10 AKAP13 SLC5A12 VPS13B	3.95e-08	192	163	9	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZFC3H1 DCN ZNF106 DST PTPRJ OSBPL11 AKAP13 MAP4K4	2.54e-07	173	163	8	869da6a65d1b9b7529c666ec44e3c8ddec2ea408
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZFC3H1 DCN ZNF106 DST PTPRJ OSBPL11 AKAP13 MAP4K4	2.54e-07	173	163	8	0672bd8a4a9d18af343d01f09253fb3388896c10
ToppCell	facs-Brain_Myeloid-Cerebellum-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZFC3H1 DCN ZNF106 DST PTPRJ OSBPL11 AKAP13 MAP4K4	2.54e-07	173	163	8	870e091ec30be01a900e1cb8b9ef1880e3b7b50d
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	ABI3BP SPSB1 DCN SVEP1 TENM4 DST SUGCT VCAN	6.07e-07	194	163	8	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	ABI3BP RASA3 MXRA8 CPZ DCN SVEP1 STAT3 VCAN	7.35e-07	199	163	8	fde2b65afde69f402f1b7b056eaa266e9fd5b227
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ABI3BP MXRA8 DCN SVEP1 DST VCAN SORCS3 PEAK1	7.35e-07	199	163	8	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ABI3BP MXRA8 CPZ DCN SVEP1 DST VCAN SORCS3	7.35e-07	199	163	8	e1849505b92820a219c5a2c35492bdd55579fb48
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ABI3BP MXRA8 CPZ DCN SVEP1 DST VCAN SORCS3	7.64e-07	200	163	8	44a68bacdb3d5bf563bd35952176995850933a81
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ABI3BP MXRA8 CPZ DCN SVEP1 DST VCAN SORCS3	7.64e-07	200	163	8	dc61016c61729f69649cfb21f6264e685ce83dea
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	ABI3BP MXRA8 TEX15 DCN SVEP1 DST VCAN SORCS3	7.64e-07	200	163	8	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZFC3H1 DCN DST PTPRJ OSBPL11 AKAP13 MAP4K4	3.82e-06	175	163	7	1ea6cf9da26601646f57fa14d558a5e9e1f0b345
ToppCell	COVID-19-kidney-Epi_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GALNT14 SLC17A4 TENM4 SHANK2 ARNT2 OSBPL10 HYDIN	4.27e-06	178	163	7	544379f5a6145429762258d426b876bb36c112f5
ToppCell	COVID-19-Heart-CM_3\|Heart / Disease (COVID-19 only), tissue and cell type	FLNC ATP6V1F NCKAP5 WDPCP XIRP2 SVIL PCDH9	4.94e-06	182	163	7	287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	FLNC ATP6V1F DST XIRP2 SVIL AKAP13 PCDH9	5.31e-06	184	163	7	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	COVID-19-Heart-Fib_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYH4 ABI3BP DCN SVEP1 TENM4 VCAN PCDH9	5.50e-06	185	163	7	8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABI3BP MXRA8 CPZ DCN SVEP1 SORCS3 GULP1	6.33e-06	189	163	7	a153b83314cf52808f685296cff8c95af3f4983d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 ABI3BP SLC17A4 NCKAP5 OSBPL10 HYDIN GULP1	6.33e-06	189	163	7	3b48b0d220cc24d5170713d61fa91f5bb6c21841
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 MYH4 PRXL2B MYOZ3 ASB14 NEB XIRP2	6.33e-06	189	163	7	d2b008f98739c6af7ee63b643011a240db20e4d8
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DST PTPRJ SVIL ARNT2 OSBPL10 SORCS3 PCDH9	6.33e-06	189	163	7	8c8ca3b30d9be6c854615459a7bfba82b427c8bc
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DST PTPRJ SVIL ARNT2 OSBPL10 SORCS3 PCDH9	6.33e-06	189	163	7	5d902a4660a27548764bf04c6de152b565da835c
ToppCell	PBMC-Severe-cDC_12\|Severe / Compartment, Disease Groups and Clusters	GALNT14 SPSB1 GPX7 NUP205 BRCA1 PRKDC KPNB1	6.55e-06	190	163	7	84ee185939bdefb10705b621a70da27701eadcee
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABI3BP MXRA8 CPZ DCN SVEP1 SORCS3 GULP1	7.02e-06	192	163	7	dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCell	droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLNC ABI3BP MXRA8 GPX7 CPZ DCN SVEP1	7.02e-06	192	163	7	f9fb24457999dc9e751a099d7f995543b9330ad4
ToppCell	facs-Bladder-nan-18m-Epithelial-bladder_mesenchymal_cell_(Car3+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPSB1 MXRA8 CPZ DCN SVEP1 VCAN DNAJA1	7.51e-06	194	163	7	f4c9fc53ae31d58096906d9305b0b4082512a7e9
ToppCell	facs-BAT-Fat-3m-Mesenchymal-mesenchymal_progenitor\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABI3BP MXRA8 GPX7 CPZ DCN SVEP1 P3H1	7.51e-06	194	163	7	da45811ba07d746e7cba7ed78882b5d98ac7397d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 CCDC30 SHANK2 PTPRJ ARNT2 VAV3 HYDIN	7.51e-06	194	163	7	93c68c31e39fa44c1d05d7d4997f4f086da4e738
ToppCell	facs-BAT-Fat-3m-Mesenchymal\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABI3BP MXRA8 GPX7 CPZ DCN SVEP1 P3H1	7.51e-06	194	163	7	76b8512fd92014b3ecc42b0a20d6d1df074cba2c
ToppCell	facs-BAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABI3BP MXRA8 GPX7 CPZ DCN SVEP1 P3H1	7.51e-06	194	163	7	ef0fa9daecd3bf43c6cf56345928cacdbee19779
ToppCell	facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABI3BP MXRA8 GPX7 DCN SVEP1 P3H1 VCAN	7.76e-06	195	163	7	69a29d03e664b72f32d41876510c62345c3aed31
ToppCell	facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLK2 MXRA8 CPZ DCN SVEP1 P3H1 VCAN	7.76e-06	195	163	7	18b01ab63ee1deae3cf29669d66fff9ca4efc5c4
ToppCell	facs-GAT-Fat-3m-Mesenchymal\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABI3BP MXRA8 GPX7 DCN SVEP1 P3H1 VCAN	7.76e-06	195	163	7	1cffae2b08dbfa1c633ce24023e89b66d28b5431
ToppCell	ASK452\|World / Donor, Lineage and Cell class of Lung cells from Dropseq	FLNC SPSB1 DCN BAZ1A VCAN DNAJA1 MAP4K4	7.76e-06	195	163	7	7efd9d3a3f5e7dfe9698a4143ce4a0f9bf3a862c
ToppCell	facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABI3BP MXRA8 GPX7 DCN SVEP1 P3H1 VCAN	7.76e-06	195	163	7	9cef6f18664518060af7c192310dddce6d70345a
ToppCell	COVID-19-kidney-TAL\|kidney / Disease (COVID-19 only), tissue and cell type	IRX1 TENM4 DST ARNT2 SORCS3 PCDH9 GULP1	8.03e-06	196	163	7	04f5eb206ed3016a737609a3ebac0c1fcabb94ef
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ABI3BP MXRA8 DCN SVEP1 VCAN PEAK1 GULP1	8.03e-06	196	163	7	97e26622d9582b092c18ff5b7e957818f99d9631
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ABI3BP MXRA8 DCN SVEP1 VCAN PEAK1 GULP1	8.03e-06	196	163	7	f429f045ba45e24717963315832150b12a115bfa
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 CCDC30 SHANK2 PTPRJ ARNT2 VAV3 HYDIN	8.03e-06	196	163	7	6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-immature_B_cell\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PLK2 POLR2A ZNF106 BRD2 OSBPL10 DNAJA1 PCDH9	8.03e-06	196	163	7	9a6e4eea19348a6e3379d3b872456ab6280cb74f
ToppCell	LPS_IL1RA_TNF\|World / Treatment groups by lineage, cell group, cell type	ABI3BP MXRA8 IRX1 DCN SVEP1 VCAN GULP1	8.30e-06	197	163	7	0a6550dce156fc81f15b1e7830d331ca50d87d06
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	ABI3BP DCN SVEP1 TENM4 DST SUGCT VCAN	8.30e-06	197	163	7	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GPX7 CPZ DCN SVEP1 TENM4 VCAN SVIL	8.30e-06	197	163	7	2744cc94883c5d0424677cf5093bbab622933e9b
ToppCell	droplet-Bladder-BLADDER-1m-Epithelial\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABI3BP MXRA8 GPX7 CPZ DCN P3H1 VCAN	8.30e-06	197	163	7	036c4c9b3ae80e2dc21c24a84504d3da0541f945
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ABI3BP DCN SVEP1 SEMA3A DST VCAN GULP1	8.30e-06	197	163	7	11a4c417f035e554431a8f03be13b5eefa3530c0
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ABI3BP MXRA8 DCN SVEP1 VCAN SORCS3 GULP1	8.57e-06	198	163	7	0a4b19c3d5e65ecd24fc2ce80ac5276c813282c7
ToppCell	droplet-Bladder-BLADDER-1m-Epithelial-bladder_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABI3BP MXRA8 GPX7 CPZ DCN P3H1 VCAN	8.57e-06	198	163	7	8f202ed4692ea2c139ff05d4805c704ee4be095c
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ABI3BP DCN SVEP1 SEMA3A DST VCAN GULP1	8.57e-06	198	163	7	17dc055e2a289496d9c5cdbf3297bdf906dc6d22
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ABI3BP MXRA8 CPZ DCN SVEP1 VCAN SORCS3	8.86e-06	199	163	7	ba586690f88fd051f449753bfe7603a2cb431782
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GPX7 CPZ DCN SVEP1 TENM4 VCAN SVIL	8.86e-06	199	163	7	103f657132e830a0e5efeb745afb4b77c208a1fa
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ABI3BP MXRA8 CPZ DCN SVEP1 VCAN SORCS3	8.86e-06	199	163	7	38ed3bc7daa993d9edcf3e7834597ebb06dd24f8
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ABI3BP MXRA8 CPZ DCN SVEP1 VCAN SORCS3	8.86e-06	199	163	7	06a7d874ff7c4616577f6e59d3118717a8c47c00
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	ABI3BP MXRA8 TEX15 DCN SVEP1 VCAN SORCS3	8.86e-06	199	163	7	c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ABI3BP MXRA8 DCN SVEP1 DST VCAN SORCS3	8.86e-06	199	163	7	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ABI3BP MXRA8 GPX7 DCN SVEP1 VCAN GULP1	8.86e-06	199	163	7	2cec0e370ee9bb3c88a7acb5519e9ea8ddb399bc
ToppCell	LPS_only-Mesenchymal_fibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	ABI3BP MXRA8 CPZ DCN SVEP1 VCAN SORCS3	8.86e-06	199	163	7	211c3a08f2d484ab7a3368006767289088f0d957
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ABI3BP MXRA8 GPX7 DCN SVEP1 VCAN GULP1	8.86e-06	199	163	7	9e87b64e16d595701c3beb07aa835afe3330bd10
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts\|LPS_only / Treatment groups by lineage, cell group, cell type	ABI3BP MXRA8 CPZ DCN SVEP1 VCAN SORCS3	8.86e-06	199	163	7	1a0add79f4e34078b3475eb11c85a4234bda197c
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ABI3BP MXRA8 DCN SVEP1 DST VCAN SORCS3	9.15e-06	200	163	7	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	Biopsy_IPF-Mesenchymal-PLIN2+_Fibroblasts\|Biopsy_IPF / Sample group, Lineage and Cell type	FLNC ABI3BP SPSB1 MXRA8 CPZ DCN SVEP1	9.15e-06	200	163	7	2c5626ea8fb4b702d4560117e53edf6cfcf1971e
ToppCell	Control_saline-Mesenchymal_fibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	ABI3BP MXRA8 TEX15 DCN SVEP1 VCAN SORCS3	9.15e-06	200	163	7	64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ABI3BP MXRA8 CPZ DCN SVEP1 DST SORCS3	9.15e-06	200	163	7	b79628fd1386aa9a3b0e9fa81def0bc100c3c073
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ABI3BP MXRA8 CPZ DCN SVEP1 DST SORCS3	9.15e-06	200	163	7	50ca6550998e461ef26dd670351060bd940765a8
ToppCell	Biopsy_Other_PF-Mesenchymal-PLIN2+_Fibroblasts\|Biopsy_Other_PF / Sample group, Lineage and Cell type	FLNC ABI3BP SPSB1 MXRA8 CPZ DCN SVEP1	9.15e-06	200	163	7	0aa316b71f195ecf17ee897e307f8928a755a637
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	ABI3BP MXRA8 DCN SVEP1 DST VCAN SORCS3	9.15e-06	200	163	7	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate\|6m / Sample Type, Dataset, Time_group, and Cell type.	BCLAF1 ZFC3H1 NEB DCN SEMA3A VCAN NIPBL	9.15e-06	200	163	7	7c261e39ac30b318511373ab7302aa53b8b81b9c
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts\|Control_saline / Treatment groups by lineage, cell group, cell type	ABI3BP MXRA8 TEX15 DCN SVEP1 VCAN SORCS3	9.15e-06	200	163	7	a1fc74c1b27e104895910bc7cdce7ba33d30df7e
ToppCell	wk_20-22-Mesenchymal-Fibroblast\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	ABI3BP MXRA8 DCN SVEP1 DST VCAN GULP1	9.15e-06	200	163	7	94bd00fb6ff0dcb668eb36ec2085f1c3128855b6
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 SPSB1 SHANK2 VCAN OSBPL10 HYDIN	3.17e-05	164	163	6	1cb5fbd7050650047ad6f2ca792118e98d58d22b
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	GCNT7 ZNF592 BAZ1A TAF2 LRRC37B HYDIN	3.28e-05	165	163	6	436ce4bc75e1ba4351c439ccad19f84ad5bcb92f
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	GCNT7 ZNF592 BAZ1A TAF2 LRRC37B HYDIN	3.28e-05	165	163	6	242bdb7654f415391fb8e9bdc06412c7eee9c97e
ToppCell	368C-Myeloid-Monocyte-CD16+_Monocyte\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	RASGRF1 KDM4C IRX1 CCDC77 USP9Y PCDH9	3.51e-05	167	163	6	dbd2b9f2f4ba7be5fdf8318094e6b078cb1d1c43
ToppCell	normal_Lymph_Node-Myeloid_cells-Pleural_Mac\|Myeloid_cells / Location, Cell class and cell subclass	FOLR3 ICAM2 LAP3 NUP205 PARP16 VAV3	3.51e-05	167	163	6	820472887f43b42ae7e44513ca3d5465fb4f71a7
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SPSB1 NAP1L3 TEX15 DCN SVEP1 VCAN	3.63e-05	168	163	6	4b2d29a7843bf45922038c093ca7ec0600756adc
ToppCell	COVID-19-kidney-PEC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GALNT14 SLC17A4 SHANK2 ARNT2 OSBPL10 HYDIN	3.63e-05	168	163	6	a086c306be430adf0632ba53e98cd8014d2de330
ToppCell	Frontal_cortex-Macroglia-POLYDENDROCYTE\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	VAPA PELI1 NCKAP5 IRX1 BRCA1 MAP4K4	3.75e-05	169	163	6	50cc0f5a022b95986949db63208a627cef9f4a69
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SPSB1 NAP1L3 TEX15 DCN SVEP1 VCAN	4.00e-05	171	163	6	5d31fc9b60329d4ae3c77e4ca679359d9314397d
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KDM4C POLR2A MDM1 ADAR MTOR DOP1A	4.41e-05	174	163	6	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CCDC18 GPX7 CPZ DCN ADHFE1 LMNTD1	4.41e-05	174	163	6	1779e67382cb2644534ffb5b9b8f28d32935f4ea
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYH1 ABI3BP MXRA8 DCN DST PEAK1	4.55e-05	175	163	6	1799a7be623dc3bf53ba580a7c47d2619969d708
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Epithelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DRC7 GALNT14 ASB14 ADGB MDH1B HYDIN	5.00e-05	178	163	6	58857bb8c13e0e1c6d9f5c1258f00fff62063d68
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Epithelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DRC7 GALNT14 ASB14 ADGB MDH1B HYDIN	5.00e-05	178	163	6	8b7df6ab8709d9ab9dff97677cc4561aec2745bc
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-skeletal_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 MYH4 ASB14 NEB FN3K XIRP2	5.00e-05	178	163	6	69f68eeab11b088fcb1f963c92eff0f1cd0e711a
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Epithelial-epithelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DRC7 GALNT14 ASB14 ADGB MDH1B HYDIN	5.00e-05	178	163	6	b0baf5667e3301898b3e45e974b8a8530af6a338
ToppCell	COVID-19-kidney-PCT-S2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GALNT14 NCKAP5 SHANK2 SUGCT OSBPL10 SLC5A12	5.33e-05	180	163	6	358923e4228035a3e90e2957392089219e90dcd7
ToppCell	COVID-19-kidney-tDL\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GALNT14 NCKAP5 SHANK2 SUGCT OSBPL10 SLC5A12	5.33e-05	180	163	6	864c895b5eaedefae86f5829fa344f7b686fb59f
ToppCell	facs-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPSB1 MXRA8 CPZ DCN SVEP1 VCAN	5.33e-05	180	163	6	12537d8a569faa69f474284d2c201475722b8ca1
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	FOLR3 PELI1 METTL4 WDPCP STAT3 PTPRJ	5.66e-05	182	163	6	dc32f8f6a3b13918eb8e93c018f5823d86344080
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 MYH1 MYH4 ABI3BP SUGCT HYDIN	5.66e-05	182	163	6	5e1b316599436740f1b30875f0ebd33c3edfb2b6
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PLK2 ABI3BP ICAM2 FZD6 DST ENTPD1	5.84e-05	183	163	6	fc9a7ba148c22d0c8a46f6bc56c772929ac496f7
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_B-GC_B_(I)\|lymph-node_spleen / Manually curated celltypes from each tissue	GALNT14 RASGRF1 TEX15 BRCA1 ENTPD1 PLK1	6.02e-05	184	163	6	057c6c2f570914fa4af84682589a86b61547d6c9
ToppCell	normal-na-Lymphocytic-lymphocyte-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	CCDC30 ZNF585B BRCA1 RBAK LRRC37B DOP1A	6.02e-05	184	163	6	2c286712428662bc4589dc5ac4011bf7ed403cb5
ToppCell	NS-moderate-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CCDC30 ADGB SHANK2 MDH1B LMNTD1 HYDIN	6.20e-05	185	163	6	5e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPSB1 POLR2A MLXIP FOXJ3 STAT3 MAP4K4	6.20e-05	185	163	6	eb7d3c1363d5fedc611f9c1a91ea823de251355e
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ABI3BP NCKAP5 TENM4 DST VCAN PLXNA2	6.20e-05	185	163	6	1ac6a32cc56d5d819649bdd99518e2ead0eead4c
ToppCell	droplet-Limb_Muscle-nan-24m-Mesenchymal-skeletal_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 MYH4 MYOZ3 ASB14 NEB XIRP2	6.20e-05	185	163	6	9245c322aae8bb9065d50dada198a5ee143a3444
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ABI3BP MXRA8 CPZ DCN SVEP1 DST	6.39e-05	186	163	6	5473283fb95cee556b1f6934cf72169b676b5bcc
ToppCell	NS-moderate-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DRC7 CCDC30 ADGB MDH1B LMNTD1 HYDIN	6.39e-05	186	163	6	85787ff207f109ec7e3c0f729ba9bda739c2fdc9
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABI3BP NCKAP5 DCN SEMA3A VCAN GULP1	6.58e-05	187	163	6	173f029dcf32af008f517912f6d110a33a9e98cf
Disease	Profound Mental Retardation	INPP5E APC LARP7 SHANK2 ENTPD1 TAF2 DYNC1H1	1.13e-05	139	160	7	C0020796
Disease	Mental Retardation, Psychosocial	INPP5E APC LARP7 SHANK2 ENTPD1 TAF2 DYNC1H1	1.13e-05	139	160	7	C0025363
Disease	Mental deficiency	INPP5E APC LARP7 SHANK2 ENTPD1 TAF2 DYNC1H1	1.13e-05	139	160	7	C0917816
Disease	cognitive behavioural therapy	B3GNTL1 POU4F3 METTL4 NEB VAV3	1.60e-05	58	160	5	EFO_0007820
Disease	eosinophil count	B3GNTL1 KDM4C PRXL2B SPSB1 CCDC18 SLC17A4 SVEP1 STAT4 ZNF585B NUP205 GRPEL1 BRCA1 PTPRJ LPO AKAP13 VAV3 PRKDC PEAK1 FER1L5 MAP4K4 CCDC9	5.79e-05	1488	160	21	EFO_0004842
Disease	mucocutaneous lymph node syndrome	PELI1 EPG5 SHANK2 PTPRJ PLXNA2	5.96e-05	76	160	5	EFO_0004246
Disease	Childhood Medulloblastoma	KDM4C APC STAT3 BRD2	8.71e-05	43	160	4	C0278510
Disease	Melanotic medulloblastoma	KDM4C APC STAT3 BRD2	8.71e-05	43	160	4	C1275668
Disease	Medullomyoblastoma	KDM4C APC STAT3 BRD2	8.71e-05	43	160	4	C0205833
Disease	Desmoplastic Medulloblastoma	KDM4C APC STAT3 BRD2	8.71e-05	43	160	4	C0751291
Disease	Adult Medulloblastoma	KDM4C APC STAT3 BRD2	8.71e-05	43	160	4	C0278876
Disease	rectum adenocarcinoma (is_implicated_in)	STAT3 STAT4	8.73e-05	3	160	2	DOID:1996 (is_implicated_in)
Disease	Medulloblastoma	KDM4C APC STAT3 BRD2	1.58e-04	50	160	4	C0025149
Disease	Intellectual Disability	INPP5E APC LARP7 KARS1 SHANK2 BRCA1 MTOR ENTPD1 TAF2 DYNC1H1	1.74e-04	447	160	10	C3714756
Disease	muscle measurement	PLK2 NEB	1.74e-04	4	160	2	EFO_0004515
Disease	Abnormality of refraction	GALNT14 TDRD9 RASGRF1 RBBP7 CPZ DCN RD3L SEMA3A AKAP13 VAV3 PEAK1 PCDH9	3.22e-04	673	160	12	HP_0000539
Disease	L lactate dehydrogenase measurement	TENM4 PTPRJ LILRB5	3.71e-04	26	160	3	EFO_0004808
Disease	Cornelia de Lange syndrome (implicated_via_orthology)	PDS5A NIPBL	4.32e-04	6	160	2	DOID:11725 (implicated_via_orthology)
Disease	amyotrophic lateral sclerosis (implicated_via_orthology)	VAPA EPG5 ZNF106	5.70e-04	30	160	3	DOID:332 (implicated_via_orthology)
Disease	Melanoma, Cloudman S91	KDM4C PXN	6.03e-04	7	160	2	C0009075
Disease	Melanoma, B16	KDM4C PXN	6.03e-04	7	160	2	C0004565
Disease	Melanoma, Experimental	KDM4C PXN	6.03e-04	7	160	2	C0025205
Disease	Melanoma, Harding-Passey	KDM4C PXN	6.03e-04	7	160	2	C0018598
Disease	Malignant neoplasm of breast	MYH1 SYT3 ADAR STAT3 STAT4 EPG5 SEMA3A ADHFE1 BRCA1 MTOR AFP OSBPL11 NIPBL VPS13B DOP1A	7.78e-04	1074	160	15	C0006142
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH1 MYH4	1.28e-03	10	160	2	DOID:0111269 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH1 MYH4	1.28e-03	10	160	2	DOID:0111602 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH1 MYH4	1.28e-03	10	160	2	DOID:0111596 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH1 MYH4	1.28e-03	10	160	2	DOID:0110454 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH1 MYH4	1.28e-03	10	160	2	DOID:0080719 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH1 MYH4	1.28e-03	10	160	2	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH1 MYH4	1.28e-03	10	160	2	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH1 MYH4	1.28e-03	10	160	2	DOID:0080326 (implicated_via_orthology)
Disease	psoriatic arthritis (is_implicated_in)	STAT3 STAT4	1.56e-03	11	160	2	DOID:9008 (is_implicated_in)
Disease	X-18913 measurement	GALNT14 BTD	1.56e-03	11	160	2	EFO_0800795
Disease	Mouth Diseases	BRCA1 DNAJA1	1.86e-03	12	160	2	C0026636
Disease	distal myopathy (implicated_via_orthology)	MYH1 MYH4	1.86e-03	12	160	2	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH1 MYH4	1.86e-03	12	160	2	DOID:2106 (implicated_via_orthology)
Disease	Pancreatic Neoplasm	APC STAT3 BRCA1 SUGCT	2.18e-03	100	160	4	C0030297
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH1 MYH4	2.19e-03	13	160	2	DOID:397 (implicated_via_orthology)
Disease	Benign tumor of pancreas	APC BRCA1	2.19e-03	13	160	2	C0347284
Disease	Sjogren's Syndrome	STAT4 GTF2I	2.19e-03	13	160	2	C1527336
Disease	Sicca Syndrome	STAT4 GTF2I	2.19e-03	13	160	2	C0086981
Disease	myopathy (implicated_via_orthology)	MYH1 FLNC MYH4	2.26e-03	48	160	3	DOID:423 (implicated_via_orthology)
Disease	Malignant neoplasm of pancreas	APC STAT3 BRCA1 SUGCT	2.34e-03	102	160	4	C0346647
Disease	Malformations of Cortical Development	MTOR DYNC1H1	2.55e-03	14	160	2	C1955869
Disease	1-methylurate measurement	SEMA3A ADHFE1	2.55e-03	14	160	2	EFO_0021173
Disease	Cortical Dysplasia	MTOR DYNC1H1	2.55e-03	14	160	2	C0431380
Disease	distal arthrogryposis (implicated_via_orthology)	MYH1 MYH4	2.93e-03	15	160	2	DOID:0050646 (implicated_via_orthology)
Disease	Metastatic melanoma	MTOR PRKDC PEAK1	3.17e-03	54	160	3	C0278883
Disease	T-Cell Lymphoma	KDM4C STAT3	3.34e-03	16	160	2	C0079772
Disease	prostate cancer (is_implicated_in)	APC STAT3 BRCA1 MTOR	3.84e-03	117	160	4	DOID:10283 (is_implicated_in)
Disease	refractive error, age at onset, Myopia	GALNT14 TDRD9 RASGRF1 POLR2A RD3L	4.12e-03	193	160	5	EFO_0004847, HP_0000545, MONDO_0004892
Disease	Carcinoma of bladder	MTOR PEAK1	4.22e-03	18	160	2	C0699885
Disease	colorectal cancer (is_implicated_in)	APC PELI1 BRCA1 PTPRJ	4.33e-03	121	160	4	DOID:9256 (is_implicated_in)
Disease	disease progression measurement	POLR2A METTL4 LMNTD1	4.47e-03	61	160	3	EFO_0008336
Disease	abdominal fat cell number	FLNC POU4F3 ZNF106 XIRP2 FARS2	4.59e-03	198	160	5	EFO_0021534
Disease	cleft lip	DST BRCA1 GVINP1 SVIL ENTPD1 MGAM2	4.65e-03	284	160	6	EFO_0003959
Disease	Pancreatic carcinoma	APC BRCA1	4.70e-03	19	160	2	C0235974
Disease	serum IgE measurement	SLC17A4 NCKAP5 GRXCR2	5.12e-03	64	160	3	EFO_0004579

Protein segments in the cluster

Peptide	Gene	Start	Entry
AHGSIVPYQAFKTKD	SUGCT	271	Q9HAC7
IPSKEHPYDAAKDSI	ATP6V1F	91	Q16864
QPFDYDPNEKSKHKF	VAPA	81	Q9P0L0
TQGYIYFHKAPSPEK	ASNS	371	P08243
FQKGDTYIPSLPKHY	EPG5	1416	Q9HCE0
YEDKKHAGPSFQPEF	VCAN	2751	P13611
DKTGKSPVFHFFEDP	ADGB	71	Q8N7X0
IEDETGPPFHLKKYS	GJA10	251	Q969M2
SLFYGKKQPHEPHDN	GVINP1	831	Q7Z2Y8
TEENYNFLPHSPSKK	AKAP13	1721	Q12802
DAGEVTYFCKEPPHK	CCDC77	156	Q9BR77
NKSPCYPGEESDKHF	DOP1A	1021	Q5JWR5
DIYKPGTAQHAPKDE	ASB14	26	A6NK59
LKYHPDKNPNEGEKF	DNAJA1	31	P31689
KDPSQPFYLGHTIKS	C1GALT1C1	161	Q96EU7
KKLGEHAYPFTFEIP	ARRB1	106	P49407
FHFSDKPQPDSKPTY	BAZ1A	941	Q9NRL2
GAYKPSFLTEQELKH	ARNT2	126	Q9HBZ2
AEYTHFYGGKKPDLP	PPIL2	16	Q13356
YAPEAPYTSHDKLKD	PDS5A	101	Q29RF7
TYHKSKGDQPLYSIP	RASA3	611	Q14644
PHTPNEKFYGVTVFK	P3H1	506	Q32P28
EFPIKSPAFTGLHDK	KCTD19	141	Q17RG1
DTYAPFPGKKHLEKA	NUP205	831	Q92621
HSPSSPSPYEKLKEF	PLA2G2C	61	Q5R387
FLEIHYKGSPNANEP	LAP3	261	P28838
YGAFIKKSPPGHDDQ	MAP4K4	86	O95819
PGYHSKKDFIATQGP	PTPRJ	1101	Q12913
THGPDKDKPFSLLYT	OR10AD1	266	Q8NGE0
YKPDSSSGQGKALHD	HOXA6	111	P31267
YDYLQHLKEPSGPSE	LTV1	66	Q96GA3
SHFLPQKAPDGKSYL	NMRAL1	161	Q9HBL8
AHDEPPAYKKNSYGV	MGAM2	1111	Q2M2H8
KGFQEPDIHFLPSYK	INPP5E	521	Q9NRR6
PDIHFLPSYKFDIGK	INPP5E	526	Q9NRR6
YKANDHKPLPIIDFG	GRXCR2	106	A6NFK2
LKLNPVGAKFDPYEH	GRPEL1	161	Q9HAV7
ALHPNKDAYKPITDA	DST	7261	Q03001
AHKLALEPDSPYKFL	DCAF8L2	321	P0C7V8
KGQKQYHHPPDDSAL	PLXNA2	341	O75051
TTFKPNSPDLAKHYK	PCDH9	926	Q9HC56
VSDHGLPYLPYDSKK	LPO	336	P22079
ISHVPKPYGNNDSAK	PEAK1	126	Q9H792
DFCPPGHNTKKASYS	DCN	311	P07585
YLDFKLDPGAKHSQP	PIR	171	O00625
RFDDKHIPGSPFTAK	FLNC	1931	Q14315
NIKFADKHVPGSPFT	FLNC	2111	Q14315
PPFKGNSVIHETEYK	MDM1	221	Q8TC05
NKAHPDNKAEFPSYL	NIPBL	931	Q6KC79
FDHDGKIIQKTPYPH	PMS2P5	31	A8MQ11
QGKDIYTIDHTKPTP	KDM4C	336	Q9H3R0
IPHYKSTGDPKGFAF	LARP7	156	Q4G0J3
EDQAHYNLPKFTVKP	LRRC37B	331	Q96QE4
EDKLGVYSLVHFSPK	LMNTD1	11	Q8N9Z9
KHHKTQPSPEDELYG	FOLR3	41	P41439
EPGAKAKFHIPSTVY	LILRB5	76	O75023
PAKGKPEAHFSLIHY	MYH1	571	P12882
PCFHPGYKKVVNVSD	ENTPD1	281	P49961
PSGYGFNLHSDKSKP	SLC9A3R1	161	O14745
VFDYTKHPSKPDPSG	RBBP4	151	Q09028
FDYTKHPAKPDPSGE	RBBP7	151	Q16576
RIKHSEGGDIPPKYF	PARP16	241	Q8N5Y8
RKKHPYVFPDGNANT	GALNT14	336	Q96FL9
HVYSFPNKQKSAEPS	PXN	116	P49023
PYLLGPKKDHAQGET	SCYL3	311	Q8IZE3
YPDPHSRNDKTKGQE	PRDM9	441	Q9NQV7
HPPKKGYDFDTVNKQ	MLXIP	91	Q9HAP2
PEVYKQSLPGSNCKH	BRCA1	1091	P38398
QYYDKKDPPATEHGN	WDPCP	61	O95876
TFDPHTEFLGPQKKT	FZD6	136	O60353
AKHYQIEPLKASPSF	ADAM30	141	Q9UKF2
KKFEPHFSISPEEGY	HYDIN	4566	Q4G0P3
VSYPFDFSKHPQEEK	CPZ	386	Q66K79
SKEGPAHEPKFQYCV	ADAR	636	P55265
KDKPPHNLTIYFGSA	GCNT7	266	Q6ZNI0
SHKNLTYTQPDSFKP	CCDC18	1391	Q5T9S5
VQQHKDGKPPYSYAS	FOXJ3	71	Q9UPW0
KPPTFGEFLSQHKAE	CCDC9	326	Q9Y3X0
KDLFDYSPPLHKNLD	BCLAF1	506	Q9NYF8
DPLPAKLSYDKSHDQ	FSTL4	541	Q6MZW2
TPEALSKHFIPYNAK	GULP1	16	Q9UBP9
YKPQSDKSETHTAFP	CENPJ	86	Q9HC77
DSGAQHPSSGEKLKY	CCDC30	221	Q5VVM6
PSHSKFLKILSGDPY	BTD	356	P43251
TDLKTDYFKPGHPQA	DRC7	496	Q8IY82
PYQSGHKDLVPDEEK	MDH1B	466	Q5I0G3
PPEHTSKFYAKGALQ	KPNB1	306	Q14974
PKAISKDHLYGTLDP	DYNC1H1	2256	Q14204
IHHAAQGPTKKYPEA	FAM183BP	71	Q6ZVS7
YSGKEHPVSSEKVAP	GPRIN1	261	Q7Z2K8
HPAFKYLAQTSGKEP	GPX7	126	Q96SL4
EAKAVPYQKFEAHPN	GTF2I	486	P78347
YDDPVNHPFISAGEK	SLC17A4	251	Q9Y2C5
PSPYDHDSLKLQKGD	SASH3	186	O75995
NSGEFVFPLDSPHKK	METTL4	361	Q8N3J2
LYEKNPDSHGYDKDP	NDUFB11	66	Q9NX14
YVPPAFSDDKFIFHK	AFP	521	P02771
KKPYNPIIGETFHCS	OSBPL11	446	Q9BXB4
QENHPSKAPVKYGEL	PELI1	6	Q96FA3
PHSDFLDYVSAPIGK	ADHFE1	156	Q8IWW8
ALHYKELEFQKGPTP	MTOR	1396	P42345
FHVFKEAYLGPADPK	TESMIN	46	Q9Y4I5
HFVQKSPGDYVPKEH	PRXL2B	161	Q8TBF2
SFPEHPAFLSKKIGQ	RTN3	161	O95197
LPAKDSNGFSDPYVK	SYT3	326	Q9BQG1
TKPPLDHNASATDYK	SVIL	896	O95425
YNGHIESKPLTIPKD	TMEM161B	66	Q8NDZ6
QLKVNGEDPYPHKFH	KARS1	86	Q15046
KAELHGPFNPYELKC	TDRD9	1146	Q8NDG6
LPTLSEKKHQDFLGY	FER1L5	1351	A0AVI2
DLGSPCKEPHKTFVY	NCKAP5	456	O14513
NFSPIEDGIKHVYKS	SORCS3	871	Q9UPU3
YEKLTPVPDSFFAKH	PRPF6	176	O94906
GDKGFESPRPYKLTH	TAF2	16	Q6P1X5
YELKDNPGVHPATFA	IRX1	96	P78414
GDHFYKRNKNLPPEE	PPM1G	401	O15355
TAYHRKIPKAPGFDQ	FN3K	261	Q9H479
AKELYPGNYKPNVTH	SIRT3	196	Q9NTG7
PAKGKPEAHFSLVHY	MYH4	571	Q9Y623
TYIIKAKPDHNDPFF	NAP1L3	376	Q99457
HFENGRGKSPYDPKL	SEMA3A	161	Q14563
LHYETFGKAAPAPQE	ICAM2	156	P13598
VSHGKNHPFKPDATY	POU4F3	66	Q15319
PKEILNGKFSYTDLH	SVEP1	2501	Q4LDE5
KNDSYKPTHYPGSDI	RD3L	11	P0DJH9
PALSAKEPLEKQHYF	RASGRF1	81	Q13972
KKPYNPIIGETFHCS	OSBPL10	476	Q9BXB5
NKDSLSAFEYPGPKR	SHANK2	506	Q9UPX8
KSFNLSALEKHGPVY	APEH	131	P13798
KGFYCHEDSQERPKP	B3GNTL1	301	Q67FW5
PFYKPVDASALGLHD	BRD2	371	P25440
KPQASGYAPKSFHVE	APC	2001	P25054
KIVYSGKVPSDNHFA	CHSY1	666	Q86X52
KSGCDFKHAPPTYED	XIRP2	3271	A4UGR9
KEHKYVLGQNSPPFS	SHF	376	Q7M4L6
ISFKVLPGDHEYPKC	TRAPPC11	51	Q7Z392
DSFRPLYTHEYKGPK	SEC62	276	Q99442
HDGKNQPSKTYPAFL	SPSB1	151	Q96BD6
EADPGSAAPYLKTKF	STAT3	696	P40763
PKDKAFGKHYSSQPC	STAT4	666	Q14765
FDGHQPLPKGEKSYE	RBAK	526	Q9NYW8
KSKGLAPDLPEDLYH	RPS13	76	P62277
FHPKPSDLHLQTGYK	POLR2A	431	P24928
NGFGIKPKHSDSYFP	ZNF592	156	Q92610
KGFPYNSDLSIHEKI	ZNF585B	221	Q52M93
THYFVKPGPSEGDLA	TENM4	2616	Q6N022
GYPHQFEDKPALSKT	USP9Y	1621	O00507
DVGFKYSVKHRPFPE	RALGAPB	1016	Q86X10
KYFEGVSPKSLKHSP	PRKDC	681	P78527
PKYPDGKTFTSQHFV	TMEM209	466	Q96SK2
YKPQLSVCNPHSGKE	VPS13B	3121	Q7Z7G8
VPDFHLSSPAKNFFK	PLK2	351	Q9NYY3
DSPKVHSYPGKQDHL	TEX15	1841	Q9BXT5
KILNTSPDGHPYEKI	ZNF239	186	Q16600
PYKNADGLIAHAAPK	ZNF629	596	Q9UEG4
FKGPHVRYIQKPDNS	ABI3BP	791	Q7Z7G0
VHVPGYDPKDKSYNN	SLC5A12	596	Q1EHB4
IPADHPSRKKGDNYY	FARS2	131	O95363
ESKGHTPPFTTYKDK	ZFC3H1	1271	O60293
NKPTVEDNHGPYISK	ZNF106	491	Q9H2Y7
PGPDTEKYARFFKHN	TTLL13	481	A6NNM8
PGEKPYESHDFSKLL	ZNF527	241	Q8NB42
NYIAPEVLSKKGHSF	PLK1	216	P53350
TLQFPYKEPEHSAGQ	VAV3	761	Q9UKW4
AHSPLPAKYIDLDKG	MXRA8	421	Q9BRK3
PPEKFNHTAISKGYR	MYOZ3	151	Q8TDC0
AVDKYFKLPHASSKP	NDC1	601	Q9BTX1
AKGKYTFSPDTPHIS	NEB	4431	P20929
HTKAYGYTLGPKDVP	NEB	4991	P20929